T1	Participants 210 218	patients
T2	Participants 486 494	patients
T3	Participants 603 611	Patients
T4	Participants 969 987	21 of 304 patients
T5	Participants 1152 1166	placebo group,
T6	Participants 1171 1187	olanzapine group
T7	Participants 1326 1353	Olanzapine-treated patients
T8	Participants 1541 1566	placebo-treated patients.
